Although beyond the scope of the present study, future studies could determine more precisely the mechanisms by which C3aR/C5aR1 agonism influences breast cancer growth, including potential effects on the function of myeloid and lymphocyte cell populations, and the ability to regulate tumor angiogenesis. Here, C5AR1 is linked to neoplasm.